BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17563126)

  • 1. Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay.
    Issa MM; Nejem RM; El-Abadla NS; El-Naby MK; Roshdy AA; Kheiralla ZA
    Clin Drug Investig; 2007; 27(7):463-7. PubMed ID: 17563126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva.
    Issa MM; Nejem RM; El-Abadla NS
    Clin Drug Investig; 2006; 26(4):223-6. PubMed ID: 17163255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.
    Carsenti-Etesse H; Farinotti R; Durant J; Roger PM; De Salvador F; Bernard E; Rouveix B; Dellamonica P
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):357-66. PubMed ID: 9842977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
    Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
    Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
    Kim MK; Nightingale C; Nicolau D
    Clin Pharmacokinet; 2003; 42(11):985-96. PubMed ID: 12908854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.
    Smit JW; Oh C; Rengelshausen J; Terlinden R; Ravenstijn PG; Wang SS; Upmalis D; Mangold B
    Pharmacotherapy; 2010 Jan; 30(1):25-34. PubMed ID: 20030470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers.
    Iqbal Z; Khan A; Naz A; Khan JA; Khan GS
    Clin Drug Investig; 2009; 29(4):275-81. PubMed ID: 19301941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation.
    Prasad VG; Achanta S; Tammineni YR; Alla GR; Thirtham MR; Rao GS
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):733-741. PubMed ID: 26458556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects.
    Raffa RB; Pawasauskas J; Pergolizzi JV; Lu L; Chen Y; Wu S; Jarrett B; Fain R; Hill L; Devarakonda K
    Clin Drug Investig; 2018 Mar; 38(3):259-268. PubMed ID: 29214506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chloroquine on the bioavailability of ciprofloxacin in humans.
    Ilo CE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo JC; Agbasi PU; Orisakwe OE
    Am J Ther; 2006; 13(5):432-5. PubMed ID: 16988539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
    Iqbal Z; Javed I; Basit A; Jan I; Khan AA
    Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
    Kays MB; Overholser BR; Mueller BA; Moe SM; Sowinski KM
    Am J Kidney Dis; 2003 Dec; 42(6):1253-9. PubMed ID: 14655198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline.
    Ohnishi M; Hitoshi K; Katoh M; Nadai M; Abe F; Kurono S; Saito H; Haniuda M; Hasegawa T
    Biol Pharm Bull; 2009 Jun; 32(6):1080-4. PubMed ID: 19483319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
    Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
    Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice.
    Karbownik A; Szałek E; Sobańska K; Grabowski T; Wolc A; Grześkowiak E
    Eur J Pharm Sci; 2017 May; 102():55-62. PubMed ID: 28232141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study.
    Weiser T; Weigmann H
    Adv Ther; 2019 Mar; 36(3):597-607. PubMed ID: 30758744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.